Circulating AIM as an Indicator of Liver Damage and Hepatocellular Carcinoma in Humans

• Tomoko Yamazaki,

  Affiliation Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Mayumi Mori,

  Affiliation Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Satoko Arai,

  Affiliation Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Ryosuke Tateishi,

  Affiliation Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Masanori Abe,

  Affiliation Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan

  ⨯
• Mihoko Ban,

  Affiliation Shunkaikai, Inoue Hospital, Nagasaki, Japan

  ⨯
• Akemi Nishijima,

  Affiliation Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Maki Maeda,

  Affiliation Shunkaikai, Inoue Hospital, Nagasaki, Japan

  ⨯
• Takeharu Asano,

  Affiliation Department of Gastroenterology, Jichi Medical University, Saitama Medical Center, Omiya, Japan

  ⨯
• Toshihiro Kai,

  Current address: Omics Group, Genomic Science Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan

  Affiliation Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Kiyohiro Izumino,

  Affiliation Shunkaikai, Inoue Hospital, Nagasaki, Japan

  ⨯
• Jun Takahashi,

  Affiliation Shunkaikai, Inoue Hospital, Nagasaki, Japan

  ⨯
• Kayo Aoyama,

  Affiliation Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Sei Harada,

  Affiliation Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan

  ⨯
• Toru Takebayashi,

  Affiliation Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan

  ⨯
• Toshiaki Gunji,

  Affiliation Center for Preventive Medicine, NTT Medical Center Tokyo, Tokyo, Japan

  ⨯
• Shin Ohnishi,

  Affiliation National Center for Global Health and Medicine, Tokyo, Japan

  ⨯
• Shinji Seto,

  Affiliation Shunkaikai, Inoue Hospital, Nagasaki, Japan

  ⨯
• Yukio Yoshida,

  Affiliation Department of Gastroenterology, Jichi Medical University, Saitama Medical Center, Omiya, Japan

  ⨯
• Yoichi Hiasa,

  Affiliation Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan

  ⨯
• Kazuhiko Koike,

  Affiliation Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

  ⨯
• Ken-ichi Yamamura,

  Affiliation Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan

  ⨯
• Ken-ichiro Inoue,

  Affiliation Shunkaikai, Inoue Hospital, Nagasaki, Japan

  ⨯
•  [ ... ],
• Toru Miyazaki

  * E-mail: tm@m.u-tokyo.ac.jp

  Affiliations Laboratory of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan, Max Planck-The University of Tokyo Center for Integrative Inflammology, Tokyo, Japan, CREST, Japan Science and Technology Agency, Tokyo, Japan

  ⨯
• [ view all ]
• [ view less ]